Nanotherapeutics for Treating Neurodegenerative Disorders

Chapter 1: Concepts, types, and treatment strategies for neurodegenerative disorders

Chapter 2: Mechanisms of transport across the Blood: Brain Barrier

Chapter 3: Need for nanotherapeutics to combat neurodegenerative disorders

Chapter 4: Nanotechnology-mediated drug delivery for addressing protein aggregation

Chapter 5: Nano carriers focusing on synuclein misfolding as a therapeutic target

Chapter 6: Therapeutic potential of stem cells-derived nanocarriers in neurological disorders

Chapter 7: Emphasizing mitochondrial dysfunction and autophagy in the treatment of neurological disorders

Chapter 8: Nanocarrier-assisted delivery of drug(s)/genetic material for the targeted treatment of neurodegenerative disease

Chapter 9: Nanotherapeutics targeting neuroinflammation

Chapter 10: Nanocarriers mediated DNA repair mechanism against neurological disorders

Chapter 11: Nanotherapy for targeted inhibition of protein kinase R-like endoplasmic reticulum kinase: Unraveling stress-induced endoplasmic reticulum kinase

Chapter 12: Nanotechnological and molecular strategies for targeted modulation of microglia in neurodegenerative diseases

Chapter 13: Nanocarriers unveiling ferroptosis as a potential therapeutic target

Chapter 14: Proteostasis maintenance through nanotechnology: Mitigating protein misfolding, mitochondrial impairment, and oxidative stress

Chapter 15: Modulation of Hippo signaling pathway dysregulation through nanotechnology for neurodegenerative disorders

Chapter 16: Nanocarriers modulating fibrinolytic pathways for the treatment of various neurological disorders

Chapter 17: Targeting glial cells through nanotherapeutic strategies in neurological disorders

Chapter 18: Oligodendrocytes as an emerging therapeutic targets in neurological disorders